Skip to main content
Top
Published in: Abdominal Radiology 12/2017

01-12-2017

Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: efficacy of combining SUV and texture parameters

Authors: Masatoyo Nakajo, Megumi Jinguji, Masayuki Nakajo, Tetsuya Shinaji, Yoshiaki Nakabeppu, Yoshihiko Fukukura, Takashi Yoshiura

Published in: Abdominal Radiology | Issue 12/2017

Login to get access

Abstract

Purpose

To retrospectively investigate the SUV-related and texture parameters individually and in combination for differentiating between F-18-fluorodeoxyglucose (FDG)-avid benign and metastatic adrenal tumors with PET/CT.

Methods

Thirteen benign adrenal tumors (BATs) and 22 metastatic adrenal tumors (MATs) with a metabolic tumor volume (MTV) > 10.0 cm3 and SUV ≥ 2.5 were included. SUVmax, MTV, total lesion glycolysis, and four textural parameters [entropy, homogeneity, intensity variability (IV), and size-zone variability] were obtained. These parameters were compared between BATs and MATs using Mann–Whitney U test, and the diagnostic performance was evaluated by the area under the curve (AUC) values derived from the receiver operating characteristic analysis. The diagnostic value of combining SUV and texture parameters was examined using a scoring system.

Results

MATs showed significantly higher SUVmax (p = 0.004), entropy (p = 0.013), IV (p = 0.006), and lower homogeneity (p = 0.019) than BATs. The accuracies for diagnosing MATs were 82.9, 82.9, 85.7, and 71.4% for SUVmax, entropy, IV, and homogeneity, respectively. No significant differences in AUC were found among these parameters (p > 0.05 each). When each parameter was scored as 0 (negative for malignancy) and 1 (positive for malignancy) according to each threshold criterion and the four parameter summed scores 0, 1, and 2 were defined as benignity and 3 and 4 as malignancy, the sensitivity and specificity and accuracy to predict MATs were 100% (22/22), 84.6% (11/13), and 94.3% (33/35), respectively, with 0.97 of the AUC.

Conclusion

The combined use of SUVmax and texture parameters has a potential to significantly increase the diagnostic performance to differentiate between large FDG-avid BATs and MATs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Boland GW, Blake MA, Hahn PF, Mayo-Smith WW (2008) Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 249:756–775CrossRefPubMed Boland GW, Blake MA, Hahn PF, Mayo-Smith WW (2008) Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 249:756–775CrossRefPubMed
2.
go back to reference Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415CrossRefPubMed Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415CrossRefPubMed
3.
go back to reference Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180:1649–1657CrossRefPubMed Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180:1649–1657CrossRefPubMed
4.
go back to reference Chong S, Ks Lee, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 26:1811–1824CrossRefPubMed Chong S, Ks Lee, Kim HY, et al. (2006) Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: diagnostic efficacy and interpretation pitfalls. Radiographics 26:1811–1824CrossRefPubMed
5.
go back to reference von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422CrossRef von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–422CrossRef
6.
go back to reference Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192:956–962CrossRefPubMed Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192:956–962CrossRefPubMed
7.
go back to reference Blake MA, Slattery JM, Kalra MK, et al. (2006) Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 238:970–977CrossRefPubMed Blake MA, Slattery JM, Kalra MK, et al. (2006) Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy-initial experience. Radiology 238:970–977CrossRefPubMed
8.
go back to reference Boland GW, Dwamena BA, Jagtiani Sangwaiya M, et al. (2011) Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259:117–126CrossRefPubMed Boland GW, Dwamena BA, Jagtiani Sangwaiya M, et al. (2011) Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259:117–126CrossRefPubMed
10.
go back to reference El Naqa I, Grigsby P, Apte A, et al. (2009) Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 42:1162–1171CrossRefPubMedPubMedCentral El Naqa I, Grigsby P, Apte A, et al. (2009) Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit 42:1162–1171CrossRefPubMedPubMedCentral
11.
go back to reference Pugachev A, Ruan S, Carlin S, et al. (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62:545–553CrossRefPubMed Pugachev A, Ruan S, Carlin S, et al. (2005) Dependence of FDG uptake on tumor microenvironment. Int J Radiat Oncol Biol Phys 62:545–553CrossRefPubMed
12.
go back to reference van Baardwijk A, Bosmans G, van Suylen RJ, et al. (2008) Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiother Oncol 87:55–58CrossRefPubMed van Baardwijk A, Bosmans G, van Suylen RJ, et al. (2008) Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. Radiother Oncol 87:55–58CrossRefPubMed
13.
go back to reference van Velden FH, Cheebsumon P, Yaqub M, et al. (2011) Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38:1636–1647CrossRefPubMedPubMedCentral van Velden FH, Cheebsumon P, Yaqub M, et al. (2011) Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging 38:1636–1647CrossRefPubMedPubMedCentral
14.
go back to reference Asselin MC, O’Connor JP, Boellaard R, Thacker NA, Jackson A (2012) Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 48:447–455CrossRefPubMed Asselin MC, O’Connor JP, Boellaard R, Thacker NA, Jackson A (2012) Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer 48:447–455CrossRefPubMed
15.
go back to reference Cook GJ, Yip C, Siddique M, et al. (2013) Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRefPubMed Cook GJ, Yip C, Siddique M, et al. (2013) Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med 54:19–26CrossRefPubMed
16.
go back to reference Werner RA, Kroiss M, Nakajo M, et al. (2016) Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography. Endocrine 53:791–800CrossRefPubMed Werner RA, Kroiss M, Nakajo M, et al. (2016) Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography. Endocrine 53:791–800CrossRefPubMed
17.
go back to reference Tn S, Kligerman S, Chen W, et al. (2013) Spatial-temporal [18F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys 85:1375–1382CrossRef Tn S, Kligerman S, Chen W, et al. (2013) Spatial-temporal [18F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. Int J Radiat Oncol Biol Phys 85:1375–1382CrossRef
18.
go back to reference Hatt M, Tixier F, Cheze Le Rest C, Pradier O, Visvikis D (2013) Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40:1662–1671CrossRefPubMed Hatt M, Tixier F, Cheze Le Rest C, Pradier O, Visvikis D (2013) Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging 40:1662–1671CrossRefPubMed
19.
go back to reference Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R (2010) Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol 49:1012–1016CrossRefPubMedPubMedCentral Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R (2010) Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol 49:1012–1016CrossRefPubMedPubMedCentral
20.
go back to reference Tixier F, Hatt M, Le Rest CC, et al. (2012) Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53:693–700CrossRefPubMedPubMedCentral Tixier F, Hatt M, Le Rest CC, et al. (2012) Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med 53:693–700CrossRefPubMedPubMedCentral
21.
go back to reference Gebejes A, Huertas R (2013) Texture characterization based on grey-level co-occurrence matrix. Proc ICTIC 2:375–378 Gebejes A, Huertas R (2013) Texture characterization based on grey-level co-occurrence matrix. Proc ICTIC 2:375–378
22.
go back to reference Cheng NM, Fang YH, Lee LY, et al. (2015) Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. Eur J Nucl Med Mol Imaging 42:419–428CrossRefPubMed Cheng NM, Fang YH, Lee LY, et al. (2015) Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. Eur J Nucl Med Mol Imaging 42:419–428CrossRefPubMed
23.
go back to reference Tixier F, Le Rest CC, Hatt M, et al. (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRefPubMedPubMedCentral Tixier F, Le Rest CC, Hatt M, et al. (2011) Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med 52:369–378CrossRefPubMedPubMedCentral
24.
go back to reference Orlhac F, Soussan M, Maisonobe JA, et al. (2014) Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med 55:414–422CrossRefPubMed Orlhac F, Soussan M, Maisonobe JA, et al. (2014) Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med 55:414–422CrossRefPubMed
25.
go back to reference Hatt M, Majdoub M, Vallières M, et al. (2015) 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med 56:38–44CrossRefPubMed Hatt M, Majdoub M, Vallières M, et al. (2015) 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med 56:38–44CrossRefPubMed
27.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
28.
go back to reference Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47:32–37PubMed Metser U, Miller E, Lerman H, et al. (2006) 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 47:32–37PubMed
29.
go back to reference Groussin L, Bonardel G, Silvéra S, et al. (2009) 18F-Fluorodexyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94:1713–1722CrossRefPubMed Groussin L, Bonardel G, Silvéra S, et al. (2009) 18F-Fluorodexyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94:1713–1722CrossRefPubMed
30.
go back to reference Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC (1999) Pheochromocytomas: imaging with 2-[Fluorine-18] fluoro-2-deoxy-d-glucose PET. Radiology 212:35–41CrossRefPubMed Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC (1999) Pheochromocytomas: imaging with 2-[Fluorine-18] fluoro-2-deoxy-d-glucose PET. Radiology 212:35–41CrossRefPubMed
31.
go back to reference Taïeb D, Sebag F, Barlier A, et al. (2009) 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med 50:711–717CrossRefPubMed Taïeb D, Sebag F, Barlier A, et al. (2009) 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med 50:711–717CrossRefPubMed
32.
go back to reference Kim YI, Cheon GJ, Paeng JC, et al. (2014) Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma. Nucl Med Commun 35:606–612CrossRefPubMed Kim YI, Cheon GJ, Paeng JC, et al. (2014) Total lesion glycolysis as the best 18F-FDG PET/CT parameter in differentiating intermediate-high risk adrenal incidentaloma. Nucl Med Commun 35:606–612CrossRefPubMed
Metadata
Title
Texture analysis of FDG PET/CT for differentiating between FDG-avid benign and metastatic adrenal tumors: efficacy of combining SUV and texture parameters
Authors
Masatoyo Nakajo
Megumi Jinguji
Masayuki Nakajo
Tetsuya Shinaji
Yoshiaki Nakabeppu
Yoshihiko Fukukura
Takashi Yoshiura
Publication date
01-12-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1207-3

Other articles of this Issue 12/2017

Abdominal Radiology 12/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.